Dr William Seth Dukes, MD | |
11234 Anderson Street Box 2000, Loma Linda, CA 92354 | |
(909) 558-7171 | |
Not Available |
Full Name | Dr William Seth Dukes |
---|---|
Gender | Male |
Speciality | Emergency Medicine |
Experience | 12 Years |
Location | 11234 Anderson Street Box 2000, Loma Linda, California |
Accepts Medicare Assignments | Yes. He accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
Identifier | Type | State | Issuer |
---|---|---|---|
1578821286 | NPI | - | NPPES |
Taxonomy | Type | License (State) | Status |
---|---|---|---|
207P00000X | Emergency Medicine | 279590 (New York) | Secondary |
207P00000X | Emergency Medicine | A126499 (California) | Primary |
Facility Name | Location | Facility Type |
---|---|---|
Loma Linda University Medical Center | Loma linda, CA | Hospital |
Group Practice Name | Group PECOS PAC ID | No. of Members |
---|---|---|
Faculty Physicians And Surgeons Of Llusm | 1153227814 | 1053 |
Cep America - California | 6103739131 | 954 |
News Archive
Building off the success of its Continuing Umbrella for Research Education Program that encourages underrepresented minority undergraduate and high school students to pursue careers in healthcare, the Cancer Institute of New Jersey is offering a related program focusing on clinical research.
Scientists explore the evidence on COVID-19 transmission associated with swimming-related activities and the effect of recommended strategies to restrict it.
SuperGen Inc. announced today that the Food and Drug Administration (FDA) has officially accepted the Orathecin™ (rubitecan) capsules' New Drug Application (NDA) for filing. Orathecin, an investigational anticancer compound, is an oral chemotherapy agent that has been investigated as a treatment for pancreatic cancer patients who have failed at least one prior chemotherapy.
A new model developed at MIT can help predict if patients at risk for Alzheimer's disease will experience clinically significant cognitive decline due to the disease, by predicting their cognition test scores up to two years in the future.
NSW Premier Kristina Keneally confirmed a proposal to raise the legal drinking age to 21 in her state that will be considered in Cabinet this week. The bill is proposed by the Christian Democrats MP Fred Nile.
› Verified 6 days ago
Entity Name | Cep America - California |
---|---|
Entity Type | Part B Supplier - Clinic/group Practice |
Entity Identifiers | NPI Number: 1023063542 PECOS PAC ID: 6103739131 Enrollment ID: O20031106000520 |
News Archive
Building off the success of its Continuing Umbrella for Research Education Program that encourages underrepresented minority undergraduate and high school students to pursue careers in healthcare, the Cancer Institute of New Jersey is offering a related program focusing on clinical research.
Scientists explore the evidence on COVID-19 transmission associated with swimming-related activities and the effect of recommended strategies to restrict it.
SuperGen Inc. announced today that the Food and Drug Administration (FDA) has officially accepted the Orathecin™ (rubitecan) capsules' New Drug Application (NDA) for filing. Orathecin, an investigational anticancer compound, is an oral chemotherapy agent that has been investigated as a treatment for pancreatic cancer patients who have failed at least one prior chemotherapy.
A new model developed at MIT can help predict if patients at risk for Alzheimer's disease will experience clinically significant cognitive decline due to the disease, by predicting their cognition test scores up to two years in the future.
NSW Premier Kristina Keneally confirmed a proposal to raise the legal drinking age to 21 in her state that will be considered in Cabinet this week. The bill is proposed by the Christian Democrats MP Fred Nile.
› Verified 6 days ago
Entity Name | Faculty Physicians And Surgeons Of Llusm |
---|---|
Entity Type | Part B Supplier - Clinic/group Practice |
Entity Identifiers | NPI Number: 1205009917 PECOS PAC ID: 1153227814 Enrollment ID: O20031211000981 |
News Archive
Building off the success of its Continuing Umbrella for Research Education Program that encourages underrepresented minority undergraduate and high school students to pursue careers in healthcare, the Cancer Institute of New Jersey is offering a related program focusing on clinical research.
Scientists explore the evidence on COVID-19 transmission associated with swimming-related activities and the effect of recommended strategies to restrict it.
SuperGen Inc. announced today that the Food and Drug Administration (FDA) has officially accepted the Orathecin™ (rubitecan) capsules' New Drug Application (NDA) for filing. Orathecin, an investigational anticancer compound, is an oral chemotherapy agent that has been investigated as a treatment for pancreatic cancer patients who have failed at least one prior chemotherapy.
A new model developed at MIT can help predict if patients at risk for Alzheimer's disease will experience clinically significant cognitive decline due to the disease, by predicting their cognition test scores up to two years in the future.
NSW Premier Kristina Keneally confirmed a proposal to raise the legal drinking age to 21 in her state that will be considered in Cabinet this week. The bill is proposed by the Christian Democrats MP Fred Nile.
› Verified 6 days ago
Mailing Address | Practice Location Address |
---|---|
Dr William Seth Dukes, MD 11234 Anderson Street Box 2000, Loma Linda, CA 92354 Ph: (909) 558-7171 | Dr William Seth Dukes, MD 11234 Anderson Street Box 2000, Loma Linda, CA 92354 Ph: (909) 558-7171 |
News Archive
Building off the success of its Continuing Umbrella for Research Education Program that encourages underrepresented minority undergraduate and high school students to pursue careers in healthcare, the Cancer Institute of New Jersey is offering a related program focusing on clinical research.
Scientists explore the evidence on COVID-19 transmission associated with swimming-related activities and the effect of recommended strategies to restrict it.
SuperGen Inc. announced today that the Food and Drug Administration (FDA) has officially accepted the Orathecin™ (rubitecan) capsules' New Drug Application (NDA) for filing. Orathecin, an investigational anticancer compound, is an oral chemotherapy agent that has been investigated as a treatment for pancreatic cancer patients who have failed at least one prior chemotherapy.
A new model developed at MIT can help predict if patients at risk for Alzheimer's disease will experience clinically significant cognitive decline due to the disease, by predicting their cognition test scores up to two years in the future.
NSW Premier Kristina Keneally confirmed a proposal to raise the legal drinking age to 21 in her state that will be considered in Cabinet this week. The bill is proposed by the Christian Democrats MP Fred Nile.
› Verified 6 days ago
Deborah Lee Behringer, MD Emergency Medicine Medicare: Accepting Medicare Assignments Practice Location: 11234 Anderson St, Cp 21005, Loma Linda, CA 92354 Phone: 909-558-4000 | |
Dr. Kristina Kyle, M.D. Emergency Medicine Medicare: Accepting Medicare Assignments Practice Location: 11234 Anderson Street, Loma Linda University Health - Emergency Medicine, Loma Linda, CA 92354 Phone: 909-558-4085 | |
Andrew Simmons, MD Emergency Medicine Medicare: Medicare Enrolled Practice Location: 11210 Benton St, Loma Linda, CA 92354 Phone: 023-500-8542 | |
Eric Theodore Teacher, M.D. Emergency Medicine Medicare: Accepting Medicare Assignments Practice Location: 11234 Anderson St, House Staff Office Cp 21005, Loma Linda, CA 92354 Phone: 909-558-8131 | |
Carol Conceicao, MD Emergency Medicine Medicare: Medicare Enrolled Practice Location: 11234 Anderson St, Loma Linda, CA 92354 Phone: 909-558-4000 | |
Grace J Kim, M.D. Emergency Medicine Medicare: Accepting Medicare Assignments Practice Location: 11234 Anderson St, Loma Linda, CA 92354 Phone: 909-558-4344 | |
Lynda Daniel-underwood, M.D. Emergency Medicine Medicare: Accepting Medicare Assignments Practice Location: 11234 Anderson St, Loma Linda, CA 92354 Phone: 909-558-4344 |